Kramofit 200 mg Injection 5 ml is indicated for the acute and chronic treatment of patients with an inborn error of metabolism that results in secondary carnitine deficiency. It is also indicated to prevent and treat carnitine deficiency in end-stage renal disease patients undergoing dialysis.
Kramofit 200 mg Injection 5 ml contains Levocarnitine, an amino acid that works by improving the levels of carnitine in the body. Thereby, Kramofit 200 mg Injection 5 ml helps treat carnitine deficiency. It may alleviate the metabolic abnormalities of patients with inborn errors that result in the accumulation of toxic organic acids.
Kramofit 200 mg Injection 5 ml will be administered by a healthcare professional; do not self-administer. In some cases, Kramofit 200 mg Injection 5 ml may cause nausea and vomiting. Most of these side effects of Kramofit 200 mg Injection 5 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to any of the components in Kramofit 200 mg Injection 5 ml, please inform your doctor. Consult your doctor if you are pregnant or breastfeeding. Let your doctor know if you are taking any prescription or non-prescription medicines, including supplements and herbal products.